Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 6, 2007
April 11, 2024
c4c75ea8-e4ee-4ab0-8ebb-c0191cd85f05
Related Documents
Role of HIV Drug Resistance Testing in Antiretroviral Drug Development
Guidance DocumentOctober 31, 2007Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR
Guidance DocumentFebruary 8, 2007Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox